Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.

Joel W. Hughes, P. Boden, B. Costall et al. · Proceedings of the National Academy of Sciences · 1990 · 504 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Enhanced Sensitivity to Cholecystokinin Tetrapeptide in Panic Disorder

Jacques Bradwejn · Archives of General Psychiatry · 1991 · 349 citations

Medicine, Pharmacology, Clinical Pharmacology +8

Cholecystokinin Tetrapeptide Induces Panic-like Attacks in Healthy Volunteers

Claude de Montigny · Archives of General Psychiatry · 1989 · 322 citations

Medicine, Pharmacology, Clinical Pharmacology +13

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.

L. Singh, Siân Lewis, Mark J. Field et al. · Proceedings of the National Academy of Sciences · 1991 · 214 citations

Medicine, Neuroscience, Pharmacology +13

The Panicogenic Effects of Cholecystokinin-Tetrapeptide Are Antagonized by L-365,260, a Central Cholecystokinin Receptor Antagonist, in Patients With Panic Disorder

Jacques Bradwejn · Archives of General Psychiatry · 1994 · 180 citations

Medicine, Pharmacology, Pharmacotherapy +13